Commercialization: Page 36
-
PharmaVoice Team/PharmaVoice
Not "Patients," But People
Finding Inspiration on Customer-Centric Marketing From Other Walks of Life Let’s not be healthcare marketers for a moment. Let’s be us: men, women, parents, grandparents, grandchildren, children, aunts, uncles, even pet parents. Sometimes we get sick. Our loved ones may suffer a heart attack. Alz...
By Johanna Skilling • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Personal Patient Connections Generate Real-world Results
In today’s plugged in, non-stop digital world, pharma brands are finding that helping patients create a personal, ongoing connection with a healthcare professional is a core catalyst for adherence to therapy, a more satisfying patient journey, brand loyalty, and — ultimately — improved patient ou...
By Abigail Mallon • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Supply Chain: The Pharma Supply Chain
The pharmaceutical supply chain is a complex system through which prescription medicines, biologics, and devices are delivered to patients. The Kaiser Family Foundation lays out the distribution channel as such: products originate in manufacturing sites, they are then transferred to wholesale dis...
By Taren Grom • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Key Questions to Ask When making Critical Channel Decisions
As the process of bringing new products to market has become increasingly complex, so too have decisions around distribution and channel strategy. When thinking about how to get products into the hands of providers and patients in the right place and at the right time, pharmaceutical companies ha...
By Jennifer Fillman • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Speak Out
Including the Elderly in Clinical Trials: A Challenge for the Ages, Solutions for Today Provided by: Artcraft Health Written by: Allison Musante, ELS Allison Musante is a copywriter and editor at Artcraft Health, a full-service health education and marketing communications agency. She has served ...
By Allison Musante • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Battery-less, Stretchable Patch Provides More Options for Health Monitoring Trending now: Innovative solutions lead to next generation mHealth tools. John Rogers, Ph.D., founder of MC10 and a materials scientist at the University of Illinois at Urbana-Champaign, has introduced a wearable electro...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
Digitas Health LifeBrands Announces Partnership with Dreamit Trending now: Agency connects with global accelerator to drive business velocity. Digitas Health LifeBrands, a leading digital agency, has formed a strategic partnership with Dreamit, a top 10 global accelerator, aimed at driving busine...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Study Reveals High Confidence in Digital Transformation Success Despite Major Challenges Trending now: Almost 70% of executives still predict digital transformation success in the face of major corporate roadblocks. While a majority of companies expect to meet digital transformation objectives i...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Quintiles Unveils Solution Design Studio Trending now: New healthcare technology and apps accelerator combines expert teams and agile processes in a highly collaborative, digitally enabled environment. Quintiles, a provider of product development and integrated healthcare services, has opened it...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
A Call for Commercial Transformation
The implementation of digital technologies will have a great impact on the way pharma marketers engage with both patients and healthcare professionals. The impact will be in terms of amplified time and efficiency, much better sales and marketing alignment, the ability to customize by audience, an...
By Robin Robinson • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Digital Advertising: Investment Slowly Climbs
Think back over the past 24 hours of your life; how many hours — or even minutes — of that time were you engaged with a mobile device? If you said none, you are in the minority. Statistics from several mobile industry reports say 64% of U.S. adults own a smartphone (Pew), 54% use mobile over comp...
By Robin Robinson • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
CNS: Specialty Audiences
On April 29, 2016, Nuplazid (pimavanserin) became the first drug approved by the FDA for the treatment of hallucinations and delusions associated with Parkinson’s disease (PD) psychosis. Its journey from molecule to market took Acadia Pharma 17 years to complete. The company is now preparing for ...
By Robin Robinson • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Germany Puts Focus on Pharma Innovation
The fourth largest economy in the world and the largest in Europe, Germany remains one of the world’s economic powerhouses. Despite some uncertainty brought about by Brexit, Germany is expected to continue to withstand economic turmoil. The pharmaceutical and chemical industry combined is the cou...
By Kim Ribbink • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Data Delivery Data Management
Some experts say cloud-based applications are the key to using leveraged data with sensors, and are the key to unleashing the power of the Internet of Things (IoT). IoT doesn’t function without cloud-based applications to interpret and transmit the data coming from all these sensors. The cloud is...
By Taren Grom • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Data, Marketing, and the Pharmaceutical Industry
It’s 2016, and we are living in an age where data is everywhere. It’s a bit like oxygen or water, data flows freely, generated by you, me, and the plethora of devices with which we interact. The planets that lined up to enable this are the ever-more powerful set of devices we possess, on-demand c...
By Ritesh Patel • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Marketing in a New World
The Institute for Healthcare Improvement’s Triple Aim initiative outlines how new healthcare designs must be developed to simultaneously pursue three dimensions: improving the patient experience of care, including quality and satisfaction; improving the health of populations; and reducing the per...
By Taren Grom • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Healthcare Marketing: Interconnectivity of Our Target Audiences and Engagement in their Dialogue
Marketing efforts in the U.S. healthcare system are evolving almost daily. The still-unfolding Affordable Care Act (“Obamacare"), continued consolidation among pharmaceutical manufacturers, and advances in communication tools have all impacted these efforts. The ways healthcare marketers communic...
By Larry Lannino • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Digital Medical Media: How to Deliver an Edge to Physicians and Advertisers Alike
What is driving the trend to provide digital engagement and messaging to physicians? Increasing numbers of physicians blocked from detailing necessitating rapid growth in non-personal communications. Also, data and ability to measure return has only recently become a meaningful reality – pharma ...
By Doug Grose • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Staying Ahead for Patients and Physicians
The healthcare system is undergoing a profound change in how care is delivered, reimbursed, and coordinated. A new emphasis on population health, patient experience, and cost per capita has been brought about through new policy (the Affordable Care Act) and effectively articulated through the “Tr...
By Patrick Beers • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Attention: Outdated Access Services Strategies Actually Reduce Access
Access services aim to solve almost everything that interferes with the progression from writing prescriptions to the patients receiving their medications. Traditional emphasis has been on reimbursement barriers, solving for coverage issues as well as affordability issues. Many also include patie...
By Nora Tsvigas • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma's New Organized Customers…Can We Connect the Dots?
Healthcare reform is rapidly moving to value-based reimbursement, prompting institutions and providers to join together and create new organizations capable of coordinating the care necessary to achieve value-based outcomes. These are the new pharma industry’s B2B customers: organized groups of i...
By John W. Draper • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Speak Out
A Fearless look at a workshop worth its salt When was the last time you attended a workshop or training session that felt worth the volume of unopened email and loss of billable work time? We often spend workshops checking our phones and sneaking peeks at the agenda to see when the next coffee br...
By Tara Bernardino • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
The Bloc Launches BlocAlley Trending now: New division helps drive commercial success for entrepreneurial health organizations. The Bloc has launched BlocAlley, a new division that helps clients in the health sector launch and commercialize themselves as well as their lead products and services. ...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Biopharma Sponsors Sell or Plan to Sell Biosimilar Products Trending now: Industry experts project there will be a biosimilar boom. The majority of companies with a large molecule offering plan to enter or are already involved in the biosimilar market, including companies with no internal manufa...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Commanders & Chiefs Julie Adrian Chandler Chicco Agency, inVentiv Health Mary Anderson Ogilvy CommonHealth Medical Educatio...
By PharmaVoice Team • Aug. 1, 2016
Previous
